Early and Late Efficacy on Wound Healing of Silver Nanoparticle Gel in Males after Circumcision.
AgNPs
circumcision
silver nanoparticles
wound dressing
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
11 Jun 2020
11 Jun 2020
Historique:
received:
15
05
2020
revised:
28
05
2020
accepted:
08
06
2020
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
18
6
2020
Statut:
epublish
Résumé
We evaluate the early and late safety and efficacy of silver nanoparticle (AgNPs) in wound healing after circumcision. This multicenter prospective comparative non-randomized observational study compares wound dressing with AgNPs (group A) vs. gentamicin cream (group B). Follow-up included objective evaluation at 10 and 30 days by the Southampton Scoring System (SSS) and Stony Brook Scar Evaluation Scale (SBSES). We enrolled 392 males: 194 in group A, and 198 in group B. At 10 days follow-up, in group A, the SSS scale was grade 1 in 49.5% and grade 2 in the remaining; meanwhile, in group B, grade 1 was in 58%, grade 2 in 34.3%, and grade 4 in 7.6%. At 30 days follow-up, grade 1 healing was 97.4% and 98.4% in group A and B, respectively. At 10 days follow-up, the mean SBSES score was 3.58 and 3.69 in group A and B, respectively; while at 30 days follow-up, 4.81 and 4.76 in group A and B, respectively. Only in group B did 7.6% of males have antibiotic therapy due to pus discharge. No patients needed surgical wound revision. AgNPs led to a late but safer healing, they were non-inferior to the antibiotic cream wound dressing efficacy, and they avoided pus discharge and the need for oral antibiotics due to their polymer material.
Identifiants
pubmed: 32545258
pii: jcm9061822
doi: 10.3390/jcm9061822
pmc: PMC7356923
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
ACS Appl Mater Interfaces. 2016 Feb 17;8(6):3958-68
pubmed: 26800283
Int J Biol Macromol. 2020 Apr 1;148:501-509
pubmed: 31958554
J Biomater Sci Polym Ed. 2017 Oct;28(14):1588-1602
pubmed: 28589745
J Urol. 2014 Dec;192(6):1667-72
pubmed: 24998482
Trends Biotechnol. 2012 Oct;30(10):499-511
pubmed: 22884769
PLoS Med. 2005 Nov;2(11):e298
pubmed: 16231970
Carbohydr Polym. 2019 Oct 15;222:114985
pubmed: 31320093
Chem Commun (Camb). 2015 Nov 11;51(87):15862-5
pubmed: 26377374
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
Minerva Urol Nefrol. 2004 Mar;56(1):15-31
pubmed: 15195028
J Pediatr Surg. 2011 Feb;46(2):366-71
pubmed: 21292089
J Plast Reconstr Aesthet Surg. 2009 Jun;62(6):713-20
pubmed: 19303834
Eur Urol. 2013 Feb;63(2):386-94
pubmed: 23031676
Biomacromolecules. 2018 Feb 12;19(2):267-278
pubmed: 28846393
Clin Microbiol Infect. 2017 Aug;23(8):577.e1-577.e3
pubmed: 28242273
JAMA Netw Open. 2018 Dec 7;1(8):e186248
pubmed: 30646318
Am J Infect Control. 2013 Oct;41(10):897-900
pubmed: 23489735
BMJ. 1992 Feb 22;304(6825):469-71
pubmed: 1547415